ZORAC

This brand name is authorized in Spain, New Zealand, Poland

Active ingredients

The drug ZORAC contains one active pharmaceutical ingredient (API):

1 Tazarotene
UNII 81BDR9Y8PS - TAZAROTENE

Tazarotene, a member of the acetylenic class of retinoids, is a prodrug which is converted to its active free form, tazarotenic acid, by de-esterification in the skin area. Tazarotenic acid is the only known metabolite of tazarotene to have retinoid activity.

Read about Tazarotene

Medication package inserts

Below package inserts are available for further reading:

Title Information Source Document Type  
ZORAC Gel Medicines & Healthcare Products Regulatory Agency (GB) MPI, EU: SmPC

Medicine classification

This drug has been classified in the anatomical therapeutic chemical (ATC) classification system as follows:

ATC code Group title Classification
D05AX05 Tazarotene D Dermatologicals → D05 Antipsoriatics → D05A Antipsoriatics for topical use → D05AX Other antipsoriatics for topical use
Discover more medicines within D05AX05

Authorization and marketing

This drug has been assigned below unique identifiers within the countries it is being marketed:

Country Identification scheme Identifier(s)
Country: ES Centro de informaciรณn online de medicamentos de la AEMPS Identifier(s): 61861, 61862
Country: NZ Medicines and Medical Devices Safety Authority Identifier(s): 11596, 11597, 7683, 7684
Country: PL Rejestru Produktรณw Leczniczych Identifier(s): 100105894, 100105902

ยฉ All content on this website, including data entry, data processing, decision support tools, "RxReasoner" logo and graphics, is the intellectual property of RxReasoner and is protected by copyright laws. Unauthorized reproduction or distribution of any part of this content without explicit written permission from RxReasoner is strictly prohibited. Any third-party content used on this site is acknowledged and utilized under fair use principles.